| ■ 영문 제목 : Global Insulin Market 2023-2027
|
 | ■ 상품코드 : IRTNTR74807-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2022년 12월
■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (24시간 이내)
■ 조사대상 지역 : 세계
■ 산업 분야 : 의료 기기
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1명 열람용) | USD2,500 ⇒환산￦3,375,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산￦5,400,000 | 견적의뢰/주문/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
테크나비오 조사회사는 세계의 인슐린 시장 규모가 2022년부터 2027년까지 연평균 1.77% 성장하여, 1662.41백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 보고서는 세계의 인슐린 시장에 대해 다방면으로 조사 및 분석하여, 개요, 시장 현황, 시장 규모, 과거 시장 규모, 파이브 포스 분석, 종류별 (인슐린 아날로그, 인간 인슐린) 분석, 판매 채널별 (소매 약국, 병원, 온라인 약국) 분석, 고객 현황, 지역별 현황 (북미, 유럽, 아시아, 미국, 영국, 독일, 중국, 일본, 기타 지역) 분석, 추진 요인/과제/동향, 기업 현황, 기업 분석 등의 항목을 게재하고 있습니다. 또한 본 조사 보고서는 AdvaCare Pharma, ASP Healthcare Pty Ltd., B. Braun SE, Becton Dickinson and Co., Biocon Ltd., Cardinal Health Inc., CODAN Medizinische Gerate GmbH and Co KG, Eli Lilly and Co., Gerresheimer AG, Gulf Pharmaceutical Industries, Healthwarehouse.com Inc., Hindustan Syringes and Medical Devices Ltd., Hi Tech Medics Pvt Ltd. 등의 기업 정보가 수록되어 있습니다.
・개요
・시장 현황
・시장 규모
・과거 시장 규모
・파이브 포스 분석
・세계의 인슐린 시장 규모 : 종류별
- 인슐린 아날로그의 시장 규모
- 인간 인슐린의 시장 규모
・세계의 인슐린 시장 규모 : 판매 채널별
- 소매 약국 채널의 시장 규모
- 병원 채널의 시장 규모
- 온라인 약국 채널의 시장 규모
・고객 현황
・지역별 현황
- 북미의 인슐린 시장 규모
- 유럽의 인슐린 시장 규모
- 아시아의 인슐린 시장 규모
- 미국의 인슐린 시장 규모
- 영국의 인슐린 시장 규모
- 독일의 인슐린 시장 규모
- 중국의 인슐린 시장 규모
- 일본의 인슐린 시장 규모
- 기타 지역의 인슐린 시장 규모
・추진 요인/과제/동향
・기업 현황
・기업 분석
테크나비오사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 테크나비오사의 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
■ 보고서 개요Global Insulin Market 2023-2027Technavio has been monitoring the insulin market and is forecast to grow by $1662.41 mn during 2022-2027, accelerating at a CAGR of 1.77% during the forecast period. Our report on the insulin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of diabetes, increasing exposure to risk factors that lead to diabetes, and favorable government initiatives.
Technavio’s insulin market is segmented as below:
By Type
• Insulin analog
• Human insulin
By Distribution Channel
• Retail pharmacies
• Hospitals
• Online pharmacies
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the advances in insulin delivery systems as one of the prime reasons driving the insulin market growth during the next few years. Also, increasing focus on home care settings and an increase in awareness of diabetes and growth initiatives will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the insulin market covers the following areas:
• Insulin market sizing
• Insulin market forecast
• Insulin market industry analysis
Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading insulin market vendors that include AdvaCare Pharma, ASP Healthcare Pty Ltd., B. Braun SE, Becton Dickinson and Co., Biocon Ltd., Cardinal Health Inc., CODAN Medizinische Gerate GmbH and Co KG, Eli Lilly and Co., Gerresheimer AG, Gulf Pharmaceutical Industries, Healthwarehouse.com Inc., Hindustan Syringes and Medical Devices Ltd., Hi Tech Medics Pvt Ltd., Mayo Foundation for Medical Education and Research, Novo Nordisk AS, Pfizer Inc., Sanofi SA, UltiMed Inc., Wockhardt Ltd., and Nipro Corp. Also, the insulin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
■ 보고서 목차• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global insulin market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global insulin market 2017 – 2021 ($ million)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.3 Distibution channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Distibution channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Insulin analog – Market size and forecast 2022-2027
o Exhibit 34: Chart on Insulin analog – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Insulin analog – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Insulin analog – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Insulin analog – Year-over-year growth 2022-2027 (%)
o 6.4 Human insulin – Market size and forecast 2022-2027
o Exhibit 38: Chart on Human insulin – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Human insulin – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Human insulin – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Human insulin – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 43: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 45: Chart on Comparison by Distribution Channel
o Exhibit 46: Data Table on Comparison by Distribution Channel
o 7.3 Retail pharmacies – Market size and forecast 2022-2027
o Exhibit 47: Chart on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Retail pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Retail pharmacies – Year-over-year growth 2022-2027 (%)
o 7.4 Hospitals – Market size and forecast 2022-2027
o Exhibit 51: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
o 7.5 Online pharmacies – Market size and forecast 2022-2027
o Exhibit 55: Chart on Online pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Online pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Online pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Online pharmacies – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 59: Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 85: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 89: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 China – Market size and forecast 2022-2027
o Exhibit 93: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 101: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 B. Braun SE
o Exhibit 108: B. Braun SE – Overview
o Exhibit 109: B. Braun SE – Business segments
o Exhibit 110: B. Braun SE – Key news
o Exhibit 111: B. Braun SE – Key offerings
o Exhibit 112: B. Braun SE – Segment focus
o 12.4 Becton Dickinson and Co.
o Exhibit 113: Becton Dickinson and Co. – Overview
o Exhibit 114: Becton Dickinson and Co. – Business segments
o Exhibit 115: Becton Dickinson and Co. – Key news
o Exhibit 116: Becton Dickinson and Co. – Key offerings
o Exhibit 117: Becton Dickinson and Co. – Segment focus
o 12.5 Biocon Ltd.
o Exhibit 118: Biocon Ltd. – Overview
o Exhibit 119: Biocon Ltd. – Business segments
o Exhibit 120: Biocon Ltd. – Key offerings
o Exhibit 121: Biocon Ltd. – Segment focus
o 12.6 Cardinal Health Inc.
o Exhibit 122: Cardinal Health Inc. – Overview
o Exhibit 123: Cardinal Health Inc. – Business segments
o Exhibit 124: Cardinal Health Inc. – Key news
o Exhibit 125: Cardinal Health Inc. – Key offerings
o Exhibit 126: Cardinal Health Inc. – Segment focus
o 12.7 CODAN Medizinische Gerate GmbH and Co KG
o Exhibit 127: CODAN Medizinische Gerate GmbH and Co KG – Overview
o Exhibit 128: CODAN Medizinische Gerate GmbH and Co KG – Product / Service
o Exhibit 129: CODAN Medizinische Gerate GmbH and Co KG – Key offerings
o 12.8 Eli Lilly and Co.
o Exhibit 130: Eli Lilly and Co. – Overview
o Exhibit 131: Eli Lilly and Co. – Product / Service
o Exhibit 132: Eli Lilly and Co. – Key offerings
o 12.9 Gerresheimer AG
o Exhibit 133: Gerresheimer AG – Overview
o Exhibit 134: Gerresheimer AG – Business segments
o Exhibit 135: Gerresheimer AG – Key news
o Exhibit 136: Gerresheimer AG – Key offerings
o Exhibit 137: Gerresheimer AG – Segment focus
o 12.10 Gulf Pharmaceutical Industries
o Exhibit 138: Gulf Pharmaceutical Industries – Overview
o Exhibit 139: Gulf Pharmaceutical Industries – Product / Service
o Exhibit 140: Gulf Pharmaceutical Industries – Key offerings
o 12.11 Hindustan Syringes and Medical Devices Ltd.
o Exhibit 141: Hindustan Syringes and Medical Devices Ltd. – Overview
o Exhibit 142: Hindustan Syringes and Medical Devices Ltd. – Product / Service
o Exhibit 143: Hindustan Syringes and Medical Devices Ltd. – Key offerings
o 12.12 Mayo Foundation for Medical Education and Research
o Exhibit 144: Mayo Foundation for Medical Education and Research – Overview
o Exhibit 145: Mayo Foundation for Medical Education and Research – Product / Service
o Exhibit 146: Mayo Foundation for Medical Education and Research – Key offerings
o 12.13 Nipro Corp.
o Exhibit 147: Nipro Corp. – Overview
o Exhibit 148: Nipro Corp. – Business segments
o Exhibit 149: Nipro Corp. – Key offerings
o Exhibit 150: Nipro Corp. – Segment focus
o 12.14 Novo Nordisk AS
o Exhibit 151: Novo Nordisk AS – Overview
o Exhibit 152: Novo Nordisk AS – Business segments
o Exhibit 153: Novo Nordisk AS – Key offerings
o Exhibit 154: Novo Nordisk AS – Segment focus
o 12.15 Pfizer Inc.
o Exhibit 155: Pfizer Inc. – Overview
o Exhibit 156: Pfizer Inc. – Product / Service
o Exhibit 157: Pfizer Inc. – Key news
o Exhibit 158: Pfizer Inc. – Key offerings
o 12.16 Sanofi SA
o Exhibit 159: Sanofi SA – Overview
o Exhibit 160: Sanofi SA – Business segments
o Exhibit 161: Sanofi SA – Key news
o Exhibit 162: Sanofi SA – Key offerings
o Exhibit 163: Sanofi SA – Segment focus
o 12.17 Wockhardt Ltd.
o Exhibit 164: Wockhardt Ltd. – Overview
o Exhibit 165: Wockhardt Ltd. – Business segments
o Exhibit 166: Wockhardt Ltd. – Key offerings
o Exhibit 167: Wockhardt Ltd. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global insulin market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Distibution channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Insulin analog – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Insulin analog – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Insulin analog – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Insulin analog – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Human insulin – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Human insulin – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Human insulin – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Human insulin – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits44: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Distribution Channel
Exhibits46: Data Table on Comparison by Distribution Channel
Exhibits47: Chart on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Online pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Online pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Online pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Online pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Distribution Channel ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: B. Braun SE – Overview
Exhibits109: B. Braun SE – Business segments
Exhibits110: B. Braun SE – Key news
Exhibits111: B. Braun SE – Key offerings
Exhibits112: B. Braun SE – Segment focus
Exhibits113: Becton Dickinson and Co. – Overview
Exhibits114: Becton Dickinson and Co. – Business segments
Exhibits115: Becton Dickinson and Co. – Key news
Exhibits116: Becton Dickinson and Co. – Key offerings
Exhibits117: Becton Dickinson and Co. – Segment focus
Exhibits118: Biocon Ltd. – Overview
Exhibits119: Biocon Ltd. – Business segments
Exhibits120: Biocon Ltd. – Key offerings
Exhibits121: Biocon Ltd. – Segment focus
Exhibits122: Cardinal Health Inc. – Overview
Exhibits123: Cardinal Health Inc. – Business segments
Exhibits124: Cardinal Health Inc. – Key news
Exhibits125: Cardinal Health Inc. – Key offerings
Exhibits126: Cardinal Health Inc. – Segment focus
Exhibits127: CODAN Medizinische Gerate GmbH and Co KG – Overview
Exhibits128: CODAN Medizinische Gerate GmbH and Co KG – Product / Service
Exhibits129: CODAN Medizinische Gerate GmbH and Co KG – Key offerings
Exhibits130: Eli Lilly and Co. – Overview
Exhibits131: Eli Lilly and Co. – Product / Service
Exhibits132: Eli Lilly and Co. – Key offerings
Exhibits133: Gerresheimer AG – Overview
Exhibits134: Gerresheimer AG – Business segments
Exhibits135: Gerresheimer AG – Key news
Exhibits136: Gerresheimer AG – Key offerings
Exhibits137: Gerresheimer AG – Segment focus
Exhibits138: Gulf Pharmaceutical Industries – Overview
Exhibits139: Gulf Pharmaceutical Industries – Product / Service
Exhibits140: Gulf Pharmaceutical Industries – Key offerings
Exhibits141: Hindustan Syringes and Medical Devices Ltd. – Overview
Exhibits142: Hindustan Syringes and Medical Devices Ltd. – Product / Service
Exhibits143: Hindustan Syringes and Medical Devices Ltd. – Key offerings
Exhibits144: Mayo Foundation for Medical Education and Research – Overview
Exhibits145: Mayo Foundation for Medical Education and Research – Product / Service
Exhibits146: Mayo Foundation for Medical Education and Research – Key offerings
Exhibits147: Nipro Corp. – Overview
Exhibits148: Nipro Corp. – Business segments
Exhibits149: Nipro Corp. – Key offerings
Exhibits150: Nipro Corp. – Segment focus
Exhibits151: Novo Nordisk AS – Overview
Exhibits152: Novo Nordisk AS – Business segments
Exhibits153: Novo Nordisk AS – Key offerings
Exhibits154: Novo Nordisk AS – Segment focus
Exhibits155: Pfizer Inc. – Overview
Exhibits156: Pfizer Inc. – Product / Service
Exhibits157: Pfizer Inc. – Key news
Exhibits158: Pfizer Inc. – Key offerings
Exhibits159: Sanofi SA – Overview
Exhibits160: Sanofi SA – Business segments
Exhibits161: Sanofi SA – Key news
Exhibits162: Sanofi SA – Key offerings
Exhibits163: Sanofi SA – Segment focus
Exhibits164: Wockhardt Ltd. – Overview
Exhibits165: Wockhardt Ltd. – Business segments
Exhibits166: Wockhardt Ltd. – Key offerings
Exhibits167: Wockhardt Ltd. – Segment focus
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations
|
| ※본 조사보고서 [세계의 인슐린 시장 (2023년~2027년)] (코드 : IRTNTR74807-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 인슐린 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!
